Peer-reviewed journals
Mesenchymal stem cells are conditionally therapeutic in preclinical models of rheumatoid arthritis. Annals of the Rheumativ Diseases. 2012;77:1733-17409.
The proteasome inhibitor bortezomib drastically affects inflammation and bone disease in adjuvant-induced arthritis in rats. Arthritis and Rheumatism. 2010;62:3277-88. Abstract
A Short Bortezomib-Course Restores the Blunted Immunomodulatory Properties of Mesenchymal Stem Cells in an Inflammatory Milieu of Experimental Arthritis, Providing Significant Clinical Benefit. Haematologica-the Hematology Journal. 2010;95:1086.
Mobilization of hematopoietic stem cells in a thalassemic mouse model: Implications for human gene therapy of thalassemia. Human Gene Therapy. 2010;21:299-310. Abstract
Mesenchymal stem cells can ameliorate adjuvant arthritis in a dose and time dependent manner. Histopathology. 2008;53:042.
A survey of tobacco viruses in tobacco crops and native flora in Greece. European Journal of Plant Pathology. 2004;110:1011-23. Abstract

